✦ LIBER ✦

Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol

✍ Scribed by Melissa A. Smith; Paul Blaker; Anthony M. Marinaki; Simon H. Anderson; Peter M. Irving; Jeremy D. Sanderson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

W1915 Further Experience of Optimising T

✍ Smith, Melissa A.; Marinaki, Anthony M.; Anderson, Simon H.; Irving, Peter M.; S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 70 KB

P534 Co-prescription of allopurinol can

✍ Beswick, L.; Dwyer, J.P.; Friedman, A.B.; Jakobovits, S.L.; Paul, E.; Headon, B. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 62 KB

Long-term outcome of using allopurinol c

✍ A. ANSARI; T. ELLIOTT; B. BABURAJAN; P. MAYHEAD; J. O’DONOHUE; P. CHOCAIR; J. SA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Safety and effectiveness of long-term al

✍ Frank Hoentjen; Margien L. Seinen; Stephen B. Hanauer; Nanne K.H. de Boer; David 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Outcomes of Pregnancies Fathered by Infl

✍ Teruel, Carlos; Román, Antonio López-San; Bermejo, Fernando; Taxonera, Carlos; P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

Sa1262 The Impact of Thiopurine Hypermet

✍ Blaker, Paul A.; Fong, Steven C.; Smith, Melissa A.; Kariyawasam, Viraj C.; Mari 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB